The MDM2 inhibitor Nutlin-3 modulates dendritic cell-induced T cell proliferation

Human Immunology

Volumn 73, Issue 4, 2012, Pages 342-345

  Gasparini, Chiara ^a   Tommasini, Alberto ^a   Zauli, Giorgio ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Antitumor therapy; Dendritic cells; Lymphocyte proliferation; P53

Indexed keywords

ANTINEOPLASTIC AGENT; NUTLIN 3;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL FUNCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

DENDRITIC CELLS; HUMANS; IMIDAZOLES; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-MDM2; T-LYMPHOCYTES;

EID: 84859089220     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.01.018     Document Type: Article

References (18)

1. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
2. Chen M., Wang J. Programmed cell death of dendritic cells in immune regulation. Immunol Rev 2010, 236:11-27.
3. Hou W.S., Van Parijs L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 2004, 5:583-589.
4. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
5. Kiaris H., Chatzistamou I., Trimis G., Frangou-Plemmenou M., Pafiti-Kondi A., Kalofoutis A. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 2005, 65:1627-1630.
6. Secchiero P., Melloni E., di Iasio M.G., Tiribelli M., Rimondi E., Corallini F., et al. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 2009, 113:4300-4308.
7. Secchiero P., di Iasio M.G., Gonelli A., Zauli G. The MDM2 inhibitor nutlins as an innovative therapeutic tool for the treatment of haematological malignancies. Curr Pharm Des 2008, 14:2100-2110.
8. Moskovits N., Kalinkovich A., Bar J., Lapidot T., Oren M. p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 2006, 66:10671-10676.
9. Secchiero P., Corallini F., Gonelli A., Dell'Eva R., Vitale M., Capitani S., et al. Antiangiogenic activity of the MDM2 antagonist nutlin-3. Circ Res 2007, 100:61-69.
10. Secchiero P., Rimondi E., Grazia di Iasio M., Voltan R., Gonelli A., Zauli G. Activation of the p53 pathway induces alpha-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages. J Cell Physiol 2012, 227:1829-1837.
11. Gasparini C., Foxwell B.M., Feldmann M. RelB/p50 regulates CCL19 production, but fails to promote human DC maturation. Eur J Immunol 2009, 39:2215-2223.
12. Liu G., Park Y.J., Tsuruta Y., Lorne E., Abraham E. p53 attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. J Immunol 2009, 182:5063-5071.
13. Petersen T.R., Dickgreber N., Hermans I.F. Tumor antigen presentation by dendritic cells. Crit Rev Immunol 2010, 30:345-386.
14. Escribano C., Delgado-Martín C., Rodríguez-Fernández J.L. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta. J Immunol 2009, 183:6282-6295.
15. Yoshimura S., Bondeson J., Foxwell B.M., Brennan F.M., Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol 2001, 13:675-683.
16. Renault V.M., Thekkat P.U., Hoang K.L., White J.L., Brady C.A., Kenzelmann Broz D., et al. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene 2011, 30:3207-3221.
17. Dijsselbloem N., Goriely S., Albarani V., Gerlo S., Francoz S., Marine J.C., et al. A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to genistein. J Immunol 2007, 178:5048-5057.
18. Monsalve E., Pérez M.A., Rubio A., Ruiz-Hidalgo M.J., Baladrón V., García-Ramírez J.J., et al. Notch-1 up-regulation and signaling following macrophage activation modulates gene expression patterns known to affect antigen-presenting capacity and cytotoxic activity. J Immunol 2006, 176:5362-5373.